Skip to content

CMPX News & Analysis

1 article

Market Mood

0 Bullish0 Neutral1 Bearish
Compass Therapeutics (CMPX) Receives Nasdaq Minimum Bid Price Compliance Notice
RegulationBearish11/21/2026

Compass Therapeutics (CMPX) Receives Nasdaq Minimum Bid Price Compliance Notice

Compass Therapeutics received a notice from Nasdaq regarding its minimum bid price compliance. This means the company's share price has fallen below Nasdaq's required minimum bid price level. Such notices are part of Nasdaq's regulatory process to ensure listed companies meet financial standards. The notice indicates that Compass Therapeutics must regain compliance by raising its stock price above the minimum threshold within a specific timeframe. Failure to do so can lead to delisting from the Nasdaq exchange. This compliance action highlights challenges facing Compass Therapeutics in maintaining its listing standards. For investors, this notice signals that Compass Therapeutics' shares currently trade below Nasdaq's minimum bid price rule. The company faces a deadline to improve its share price or take other actions to satisfy Nasdaq's requirements. This situation can affect investor confidence and liquidity in the short term.

Read More: Compass Therapeutics (CMPX) Receives Nasdaq Minimum Bid Price Compliance Notice